Oncolytics to list 5.06 million more shares Feb. 8 Oncolytics Biotech Inc (C:ONC)
Shares Issued 71,251,335
Last Close 2/6/2012 $5.37
Tuesday February 07 2012 - Prospectus Approved
Oncolytics Biotech Inc. will list an additional 5,065,750 shares on the Toronto Stock Exchange at the open on Wednesday, Feb. 8, 2012, according to the TSX. As in a Jan. 25, 2012, prospectus supplement, Oncolytics plans to sell 4,405,000 shares at $4.20 each, raising $18,501,000. It has granted the underwriters an overallotment option to buy up to 660,750 more shares at the same price for 30 days from the closing of the offering. It plans to use the money raised for its continuing head and neck cancer study, for research and development, for manufacturing, and for general corporate purposes.
© 2012 Canjex Publishing Ltd.